CIK 0001746466 · Non-accelerated filer<br>Smaller reporting company
Equillium, Inc.
Sign in to watch- Ticker
- EQ
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 821554746
- Phone
- (858) 412-5302
- Business address
- 2223 AVENIDA DE LA PLAYA, SUITE 105, LA JOLLA, CA, 92037
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-11-16 | Zedelmayer Christine Sr. Vice President and COO | Sale | −7,350 | $5.49 | $40K | 102,409 |
| 2021-11-16 | Zedelmayer Christine Sr. Vice President and COO | Option exercise · Employee Stock Option | −8,334 | 41,666 | ||
| 2021-11-16 | Zedelmayer Christine Sr. Vice President and COO | Option exercise · Employee Stock Option | −15,000 | 75,000 | ||
| 2021-10-06 | Connelly Stephen Chief Scientific Officer | Option exercise | +5,625 | $4.75 | $27K | 998,625 |
| 2021-10-06 | Connelly Stephen Chief Scientific Officer | Sale | −5,625 | $7.01 | $39K | 993,000 |
| 2021-10-06 | Connelly Stephen Chief Scientific Officer | Option exercise | +2,467 | $2.80 | $7K | 995,467 |
| 2021-10-06 | Connelly Stephen Chief Scientific Officer | Sale | −2,467 | $7.01 | $17K | 993,000 |
| 2021-10-06 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −5,625 | 0 | ||
| 2021-10-06 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −2,467 | 0 | ||
| 2021-09-27 | Keyes Jason A Chief Financial Officer | Sale | −8,000 | $6.74 | $54K | 102,720 |
| 2021-07-27 | Keyes Jason A Chief Financial Officer | Sale | −5,000 | $5.72 | $29K | 110,720 |
| 2021-06-10 | Zedelmayer Christine Sr. Vice President and COO | Grant or award | +9,032 | $2.35 | $21K | 90,509 |
| 2021-06-10 | Keyes Jason A Chief Financial Officer | Grant or award | +5,535 | $2.35 | $13K | 17,711 |
| 2021-06-10 | Rothman Joel Chief Development Officer | Grant or award | +7,742 | $2.35 | $18K | 22,991 |
| 2021-06-08 | Connelly Stephen Chief Scientific Officer | Option exercise | +10,495 | $4.75 | $50K | 1,003,495 |
| 2021-06-08 | Connelly Stephen Chief Scientific Officer | Sale | −10,495 | $7.18 | $75K | 993,000 |
| 2021-06-08 | Connelly Stephen Chief Scientific Officer | Option exercise · Employee Stock Option (right to buy) | −10,945 | 0 | ||
| 2021-06-07 | Connelly Stephen Chief Scientific Officer | Option exercise | +8,490 | $2.80 | $24K | 1,001,490 |
| 2021-06-07 | Connelly Stephen Chief Scientific Officer | Sale | −8,490 | $7.08 | $60K | 993,000 |
| 2021-06-07 | Connelly Stephen Chief Scientific Officer | Option exercise | +13,900 | $4.75 | $66K | 1,006,900 |
Page 13 of 17 · 339 trades